RESULTS: Demographic risk factors often associated with underimmunization were significantly higher for AI/AN respondents compared with white respondents in most years studied. Overall, vaccination coverage was similar between the 2 groups in most years, although coverage with 4 or more doses of pneumococcal conjugate vaccine was lower for AI/AN children in 2008 and 2009, as was coverage with vaccine series measures the series in 2006 and 2009. When stratified by geographic regions, AI/AN children had coverage that was similar to or higher than that of white children for most vaccines in most years studied.
CONCLUSIONS:
The gains in vaccination coverage found in 2005 have been maintained. The absence of disparities in coverage with most vaccines between AI/AN children and white children from 2006 through 2010 is a clear success. These types of periodic reviews are important to ensure we remain vigilant. Pediatrics 2012;130: e1592-e1599 AUTHORS: Amy V. Groom According to the 2010 census, the AI/AN population represents ∼1.7% of the US population 7 . AI/AN people receive health care from a variety of sources including the Indian Health Service (IHS) and private and/or public health insurance programs. 8, 9 The IHS is a federal health program for AI/AN people that provides care through a network of IHS, tribal, and urban Indian health facilities (I/T/U) to eligible AI/AN people. Approximately 2 million AI/AN people, 38% of the total US AI/AN population, are eligible to receive care at these predominantly rural I/T/U health facilities. 10 However, some AI/ AN people who are eligible for care may not reside near an I/T/U facility, as the majority of AI/AN people reside in urban areas. 11, 12 In addition, some AI/ AN people are not eligible to receive care from the I/T/U system because they are not enrolled members of a federally recognized tribe. While IHS monitors vaccination coverage among AI/AN children served by an I/T/U facility, 13 it cannot produce national estimates of vaccination coverage for the AI/AN population. 
Demographic Variable Definitions
Demographic characteristics of the children in the sample were obtained during the telephone interview of the parent/guardian, as part of routine NIS data collection. Poverty level was determined by using household reported income level, number of people reported living in the household and US poverty thresholds. Characteristics of providers are provider-reported (ie, provider type). Three additional geographic variables were included: IHS Contract Health Service Delivery Areas, or CHSDAs, are defined by IHS and represent the catchment area for IHS-funded facilities. For regional comparisons, the IHS administrative areas were combined into 6 larger regions as has been done in previous studies. 22 Lastly, Metropolitan Statistical Area (MSA) was used for urban versus rural comparisons.
Statistical Methods
The percentage of AI/AN children who were vaccinated was compared with the percentage of white children vaccinated by using Wald x 2 tests. Proportions are reported along with 95% confidence intervals (CIs). Data were weighted to adjust for households having multiple telephone lines, nonassessment of households without telephones, household unit nonresponse, provider nonresponse, and to reflect population demographic totals. A 2-sided significance level of .05 was adopted for all statistical tests. Analysis were conducted by using SAS, release 9.2 (SAS, Cary, NC) and SUDAAN, release 10.0 (Research Triangle Institute, Research Triangle Park, NC) to take into account the complex nature of the survey.
RESULTS
There were no differences in vaccination coverage estimates between children who were AI/AN-only compared with AI/ AN in combination with another race with the one exception of 3+HepB in 2008 (91.5% vs 98.6%, P = .01). All subsequent AI/AN results refer to the combined group of AI/AN alone or in combination with another race. AI/AN sample sizes are included in Table 1 , and ranged from 421 to 519 in any given year.
For all 5 years examined, AI/AN children were more likely than white children to live below the poverty level, have younger mothers, and have mothers with less education (Table 1) . Mothers of AI/AN children were also less likely than mothers of white children to have ever been married. In 2006-2008, AI/AN children were significantly more likely to live in a household with more children; additional results are presented in Table 1 .
Overall there were no significant differences in vaccination coverage between AI/AN and white children with the following vaccines in any of the 5 survey years: 4+DTaP, 3+polio, 3+Hib, or 3+HepB (Table 2 and Fig 1) There were some differences in vaccination coverage levels between AI/AN children and white children in all 6 regions (Table 3) (Table  3) . For all years studied, between 63% and 69% of AI/AN children resided in a CHSDA county. There were no significant differences in vaccine coverage among AI/AN children residing in a CHSDA county compared with AI/AN children not residing in a CHSDA county. There were few differences in coverage between AI/AN children residing in an MSA versus non-MSA; coverage with 4: 
DISCUSSION
From 2006 through 2010, few differences in vaccination coverage between AI/AN and white children were found. Indeed, in some regions (Southwest and Alaska), coverage for AI/AN children was frequently higher than that for white children. Instances of significantly lower coverage for AI/AN children were relatively rare, and by 2010 there was no evidence of vaccination coverage disparities between AI/AN children and white children. These 24 To ensure vaccine was provided to those at higher risk, the Advisory Committee on Immunization Practices (ACIP) recommended that AI/AN children continue to receive the full Hib series, and PedvaxHib vaccine from the CDC stockpile was made available for use in this population. 25 In 2009, coverage with the 4:3:1:3:3:1 series nationally was higher for AI/AN children compared with white children. There was no difference in Hib vaccine coverage among AI/AN children compared with white children nationally, although 2 IHS regions (Alaska, Southwest) did achieve higher Hib coverage among AI/ AN children in 2008 and 2009. Both Alaska and the Southwest used PedvaxHib vaccine almost exclusively even before the shortage, whereas other regions used a mix of Hib products, which may explain why the higher Hib vaccine coverage was limited to these regions. Higher coverage with other vaccines in both these regions in 2008 and in Alaska in 2009, however, suggest that the AI/AN Hib recommendation was not the only contributing factor to the increased coverage reported among AI/AN children in these regions. Reasons for increased coverage in these 2 regions may be related to population characteristics such as geographical concentration (eg reservations/villages) with an I/T/U facility in close proximity and the use of public health nurses to support immunization activities. 1, 4, 5 In addition, higher immunization coverage among Alaska Natives compared with whites in Alaska has been noted in previous years 5, 26 and is likely a result of the collaborative efforts between state and tribal entities to deliver immunizations in remote Alaska Native villages. We could not determine if these differences were true differences or were due to random fluctuations in estimates from year to year. The sample size of AI/AN children is relatively small in the NIS in any one year, leading to large CIs around the estimates. Additionally, numerous statistical comparisons were made in this study with no correction made for multiple comparisons; therefore, some comparisons are likely to be statistically significant by chance alone. However, because the 4+PCV differences were found for 2 consecutive years, they may be more likely to have been true differences. It is unclear why coverage would have been lower for AI/AN children than for white children in 2008 and 2009, but it may be that coverage among AI/AN children was not increasing at the same rate as coverage among white children (Fig 1) . Because certain AI/AN populations have an elevated rate of invasive pneumococcal disease compared with other populations, 1 maintaining high PCV coverage for AI/AN children is important. In addition, while coverage at 2 years of age is helpful for monitoring disparities, looking at timeliness of vaccination before 2 years of age may provide additional insight. Future studies to examine the timeliness of vaccination in this population are needed.
Because the NIS is a random-digit-dial survey that samples at the proportion present in the population, the sample size of AI/AN children is relatively small each year. have produced some bias by excluding children of mixed Hispanic-AI/AN parents. Fourth, the sample size of AI/ AN children in any one year of the NIS is small, resulting in large CIs for the estimates. Because of the small sample size, there is much lower statistical power to detect small differences in vaccination coverage between AI/AN and other children, especially at subnational levels. Last, a large number of statistical comparisons were made in this study and thus some were likely to be statistically significant by chance alone.
CONCLUSIONS
The gains in vaccination coverage found in 2005 by a previous study have been maintained. 4 The absence of disparities in coverage with most vaccines between AI/AN children and white children from 2006 through 2010 is a clear success, although the ongoing presence of risk factors related to underimmunization and disparities in PCV coverage for 2 years highlights the need to continue these types of periodic reviews. ----------2007  -----------2008  -----------2009  -----------2010 - 
